Literature DB >> 16946676

Posterior hyaloid contracture in pediatric vitreoretinopathies.

Mandar M Joshi1, Stefano Ciaccia, Michael T Trese, Antonio Capone.   

Abstract

BACKGROUND: Retinal detachment in pediatric vasoproliferative disorders such as retinopathy of prematurity (ROP) and familial exudative vitreoretinopathy (FEVR) have an exudative and tractional component. Younger eyes have an especially adherent posterior hyaloid. Contraction of the posterior hyaloid interface may lead to tractional retinal detachment.
METHODS: Retrospective chart review of six eyes (four ROP, two FEVR) with diffuse contraction of the posterior hyaloid resulting in retinal detachment. Fundus photographs and optical coherence tomography findings (one eye) are presented.
RESULTS: Diffuse proliferation along the posterior hyaloid required extensive lamellar dissection at times aided by autologous plasmin enzyme. A diffuse, taut posterior hyaloid resulted in marked tractional component to retinal detachment.
CONCLUSIONS: Recognition of hyaloid contracture will aid in the proper diagnosis and surgical planning and repair of eyes with pediatric vasoproliferative disorders.

Entities:  

Mesh:

Year:  2006        PMID: 16946676     DOI: 10.1097/01.iae.0000244287.63757.5a

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  10 in total

1.  Preretinal and intraretinal exudates in familial exudative vitreoretinopathy.

Authors:  Shelley Day; Ramiro S Maldonado; Cynthia A Toth
Journal:  Retina       Date:  2011-01       Impact factor: 4.256

2.  Ultra-wide-field scanning laser ophthalmoscopy assists in the clinical detection and evaluation of asymptomatic early-stage familial exudative vitreoretinopathy.

Authors:  Jiao Lyu; Qi Zhang; Shi-Yuan Wang; Yi-Ye Chen; Yu Xu; Pei-Quan Zhao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-07-14       Impact factor: 3.117

3.  Insights into advanced retinopathy of prematurity using handheld spectral domain optical coherence tomography imaging.

Authors:  Sai H Chavala; Sina Farsiu; Ramiro Maldonado; David K Wallace; Sharon F Freedman; Cynthia A Toth
Journal:  Ophthalmology       Date:  2009-09-18       Impact factor: 12.079

4.  Vitreomacular interface in patients with familial exudative vitreoretinopathy.

Authors:  Akito Shimouchi; Atsushi Takahashi; Taiji Nagaoka; Akihiro Ishibazawa; Akitoshi Yoshida
Journal:  Int Ophthalmol       Date:  2013-01-19       Impact factor: 2.031

5.  LONGITUDINAL CHANGES IN THE OPTIC NERVE HEAD AND RETINA OVER TIME IN VERY YOUNG CHILDREN WITH FAMILIAL EXUDATIVE VITREORETINOPATHY.

Authors:  Jonghyun Lee; Mays A El-Dairi; Du Tran-Viet; Shwetha Mangalesh; Alexandria Dandridge; Kim Jiramongkolchai; Christian Viehland; Cynthia A Toth
Journal:  Retina       Date:  2019-01       Impact factor: 4.256

6.  Spectral domain optical coherence tomography characterization of pediatric epiretinal membranes.

Authors:  Adam L Rothman; Francisco A Folgar; Amy Y Tong; Cynthia A Toth
Journal:  Retina       Date:  2014-07       Impact factor: 4.256

7.  Lens subluxation after plasmin and SF6 injections in rabbit eyes.

Authors:  Wei-Chi Wu; Chi-Hsien Liu; Nan-Kai Wang; Kwan-Jen Chen; Tun-Lu Chen; Yih-Shiou Hwang; Pei-Ju Liao; Lien-Min Li; Chi-Chun Lai
Journal:  PLoS One       Date:  2014-11-14       Impact factor: 3.240

Review 8.  Familial Exudative Vitreoretinopathy.

Authors:  Selçuk Sızmaz; Yoshihiro Yonekawa; Michael T Trese
Journal:  Turk J Ophthalmol       Date:  2015-08-05

9.  Clinical characteristics of primary pars plana vitrectomy combined with air filling for rhegmatogenous retinal detachment.

Authors:  Changzhong Xu; Jianhua Wu; Yanzi Li; Rui Zhang; Chao Feng
Journal:  Sci Rep       Date:  2022-05-12       Impact factor: 4.996

10.  Efficient vitreolysis by combining plasmin and sulfur hexafluoride injection in a preclinical study in rabbit eyes.

Authors:  Wei-Chi Wu; Chi-Hsien Liu; Chih-Chun Chen; Nan-Kai Wang; Kwan-Jen Chen; Tun-Lu Chen; Yih-Shiou Hwang; Lien-Min Li; Chi-Chun Lai
Journal:  Mol Vis       Date:  2012-09-19       Impact factor: 2.367

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.